Antiviral drugs

Details

• Personal Author:
  Noti JD ; Othumpangat S ; Ray SD
• Description:
  The Side Effects of Drugs Annuals are a series of volumes in which the adverse effects of drugs and adverse reactions to them are surveyed. This review of the January 2015 to December 2015 publications on antiviral drugs includes drugs that are active against cytomegalovirus (cidofovir, foscarnet, ganciclovir and valganciclovir), drugs that are active against herpesviruses (aciclovir, famciclovir and valaciclovir), drugs that are active against hepatitis viruses (adefovir, boceprevir, telaprevir, ribavirin,telbivudine, faldaprevir, sofosbuvir and simeprevir), drugs that are active against HIV, including nucleoside analogue reverse transcriptase inhibitors (didanosine, emtricitabine, lamivudine, stavudine and zidovudine), the nucleotide analogue reverse transcriptase inhibitor tenofovir, nonnucleoside reverse transcriptase inhibitors (efavirenz, etravirine, nevirapine and rilpivirine), protease inhibitors (amprenavir/fosamprenavir, atazanavir, darunavir, lopinavir, ritonavir and saquinavir), the inhibitor of HIV fusion enfuvirtide, the integrase inhibitor dolutegravir and raltegravir, and the chemokine receptor CCR5 antagonist maraviroc, and drugs active against influenza viruses, including the neuraminidase inhibitor oseltamivir and the ion channel inhibitor imiquimod. [Description provided by NIOSH]
• Subjects:
  Communicable Diseases HIV Occupational Health Preventive Medicine Safety Viral Diseases
• Keywords:
  Adverse Reactions Amprenavir Antiretroviral Drugs Atazanavir Author Keywords: Adefovir Boceprevir Chemokine Receptor CCR5 Antagonists Cidofovir Cytomegalovirus Darunavir Didanosine Dolutegravir Drugs Efavirenz Emtricitabine Enfuvirtide Etravirine Famciclovir Fosamprenavir Foscarnet Ganciclovir Hepatitis Viruses Herpesviruses Imiquimod Infection-control Infectious-diseases Influenza Viruses Inhibitors Of HIV Fusion Integrase Inhibitors Ion Channel Inhibitors Lamivudine Lopinavir Maraviroc Neuraminidase Inhibitors Nevirapine Non-nucleoside Reverse Transcriptase Inhibitors Nucleoside Analogue Reverse Transcriptase Inhibitors Nucleotide Analogue Reverse Transcriptase Inhibitor Oseltamivir Preventive-medicine Protease Inhibitors Raltegravir Ribavirin Rilpivirine Ritonavir Simeprevir Sofosbuvir Stavudine Telaprevir Tenofovir Tipranavir Treatment Valaciclovir Valganciclovir Viral-diseases Viral-infections

  More +
• ISBN:
  9780444637185
• ISSN:
  0378-6080
• Publisher:
  Elsevier
• Document Type:
  Text
• Genre:
  Book
• Place as Subject:
  Massachusetts ; OSHA Region 1 ; OSHA Region 3 ; West Virginia
• CIO:
  National Institute for Occupational Safety and Health (NIOSH)
• Division:
  HELD - Health Effects Laboratory Division
• Topic:
  Workplace Safety & Health
• Location:
  North America
• Pages in Document:
  261-281
• Volume:
  38
• NIOSHTIC Number:
  nn:20048922
• Citation:
  Side effects of drugs annual: a worldwide yearly survey of new data in adverse drug reactions. Ray SD, ed. Waltham, MA: Elsevier, 2016 Nov; 38:261-281
• Contact Point Address:
  Sreekumar Othumpangat, Allergy and Clinical Immunology Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, 1095 Willowdale Road, Morgantown, WV 26505
• Email:
  seo8@cdc.gov
• Editor(s):
  Ray SD
• Federal Fiscal Year:
  2017
• NORA Priority Area:
  Healthcare and Social Assistance
• Peer Reviewed:
  True
• Source Full Name:
  Side effects of drugs annual: a worldwide yearly survey of new data in adverse drug reactions
• Collection(s):
  National Institute for Occupational Safety and Health
• Main Document Checksum:
  urn:sha-512:9324d15bfb1cc7dbef0f6489b5978c9bcc6a818d8c7692724552aaec6a4757786ad673562627960f1984672ad3efa702c0a19703390989b8961bf21a8a9d3d15
• Download URL:
  https://stacks.cdc.gov/view/cdc/203538/cdc_203538_DS1.pdf
• File Type:
  [PDF - 410.33 KB ]